Nexgel (NXGL) Revenue (2018 - 2025)

Nexgel's Revenue history runs 8 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• Quarterly Revenue fell 8.06% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.4 million (up 31.46% YoY) and the FY2025 annual result came in at $11.4 million, up 31.46% from the prior year.
• Revenue was $2.8 million for Q4 2025 at Nexgel, down from $2.9 million in the prior quarter.
• Across five years, Revenue topped out at $3.0 million in Q4 2024 and bottomed at $267000.0 in Q1 2021.
• A 5-year average of $1.4 million and a median of $1.1 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2021 — Revenue surged 427.72% — and 2025, when it dropped 8.06%.
• Nexgel's Revenue stood at $533000.0 in 2021, then retreated by 1.69% to $524000.0 in 2022, then jumped by 106.49% to $1.1 million in 2023, then surged by 181.05% to $3.0 million in 2024, then dropped by 8.06% to $2.8 million in 2025.
• Business Quant data shows NXGL's Revenue at $2.8 million in Q4 2025, $2.9 million in Q3 2025, and $2.9 million in Q2 2025.